SummitTX Capital’s Nutrien NTR Stock Holding History

SummitTX Capital’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,251	Closed	-$262K	–	909
2025 Q4	$262K	Buy	+4,251	New	+$250K	0.01%	612

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SummitTX Capital's NTR Position: Q1 2026 in Review

SummitTX Capital sold out of Nutrien (NTR) in Q1 2026, closing a stake of 4,251 shares — an estimated $262K sold.

SummitTX Capital first reported a position in NTR in Q4 2025 and held it in 1 quarter. The position peaked at $262K in Q4 2025. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

SummitTX Capital reported no remaining Nutrien position as of Q1 2026 after selling out during the quarter.
SummitTX Capital sold 4,251 Nutrien shares in Q1 2026, an estimated $262K.
SummitTX Capital first reported a position in Nutrien in Q4 2025 and held it in 1 quarter.
SummitTX Capital's Nutrien position peaked at $262K in Q4 2025.
747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.